Order Book analysis by شرکت سرمایه گذاری نورهمدانیان about Stock سصفها: Buy recommendation (5/12/2025)
https://sahmeto.com/message/3507606
شرکت سرمایه گذاری نورهمدانیان
Rank: 163
Analytical Power:
3.9
Norramanian Investment Company bought 0.306 million shares of Syntrhea on 22/02/404 and currently accounts for 1.17 % of the Synthetic shares in its joint portfolio.
Translated from: Farsi
Show Original Message
Signal Type: Buy
Source Message:
Price at Publish Time:
25,000